CP-102

N/A

Report date: 2024/10/21 15:48:39
NME

Base Information

Drug NameCP-102
Drug Alias NameCP-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interferenceASPA gene inhibitors
TargetsAspartoacylase
Therapy Area/IndicationsCanavan Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesContera Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesContera Pharma A/S
Inactive CompaniesN/A
Active IndicationsCanavan Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A